+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuromodulation Devices Market by Device Type (Invasive Devices, Noninvasive Devices), Control Mechanism (Closed Loop, Open Loop), Technology, Age Group, Therapeutic Area, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Neuromodulation Devices Market by Device Type (Invasive Devices, Noninvasive Devices), Control Mechanism (Closed Loop, Open Loop), Technology, Age Group, Therapeutic Area, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Neuromodulation Devices Market by Device Type (Invasive Devices, Noninvasive Devices), Control Mechanism (Closed Loop, Open Loop), Technology, Age Group, Therapeutic Area, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666253
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Neuromodulation devices are transforming clinical care by offering targeted and adaptable solutions for neurological and psychiatric disorders. Senior decision-makers seeking actionable insights and strategic clarity will find this report foundational for navigating ongoing changes in the neuromodulation landscape and optimizing future investments.

Market Snapshot: Neuromodulation Devices Market Overview

The Neuromodulation Devices Market grew from USD 5.08 billion in 2024 to USD 5.45 billion in 2025, and is projected to reach USD 7.80 billion by 2030, advancing at a CAGR of 7.40%. This robust growth trajectory highlights escalating demand for innovative solutions as healthcare systems prioritize interventions that enhance patient outcomes and reduce dependence on pharmacological strategies. As chronic neurological conditions become increasingly prevalent, neuromodulation continues to gain momentum as a core technology within modern healthcare delivery, driving both R&D and commercial expansion opportunities.

Scope & Segmentation

This comprehensive report examines neuromodulation device technologies, adoption drivers, and market dynamics across core segments and global regions. The analysis encompasses:

  • Device Types: Deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, transcranial direct current stimulation, and transcranial magnetic stimulation.
  • Control Mechanisms: Closed loop and open loop neuromodulation platforms for precise and adaptive therapeutic delivery.
  • Technologies: Solutions leveraging electrical, magnetic, optogenetic, and ultrasonic stimulation modalities.
  • Age Groups: Adult, geriatric, and pediatric populations facing varying anatomical and neurophysiological requirements.
  • Therapeutic Areas: Applications extend to gastrointestinal and urological disorders, dystonia, epilepsy, Parkinson’s disease, chronic and neuropathic pain, depression, and obsessive-compulsive disorder.
  • End Users: Ambulatory surgical centers, clinics, hospitals, and research institutes integrating neuromodulation into patient care pathways.
  • Distribution Channels: Offline medical equipment suppliers and online platforms providing digital ordering and remote support.
  • Geographies: Detailed regional coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, with analysis of major countries and states such as the United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan.
  • Competitive Landscape: Features key players including Abbott Laboratories, Aleva Neurotherapeutics SA, Biotronik SE & Co. KG, Boston Scientific Corporation, BrainsWay Ltd., ElectroCore, Inc., Integer Holdings Corporation, Laborie, Life Science Outsourcing, Inc., LivaNova PLC, Medtronic plc, Neuromod Devices Limited, Neuronetics, Inc., Neuropace Inc., NeuroSigma, Inc., Nexstim Oyj, Saluda Medical Pty Ltd, Soterix Medical Inc., Synapse Biomedical Inc., Synergia Medical SA, and tVNS Technologies GmbH.

Key Takeaways for Senior Decision-Makers

  • Technological advances are enhancing device miniaturization, enabling less invasive treatments and integration with real-time monitoring and analytics.
  • Artificial intelligence and machine learning are increasingly used to optimize device programming and personalize patient therapy, improving patient safety and outcomes.
  • Value-based reimbursement models are shaping adoption, as payers recognize the long-term cost benefits of neuromodulation therapies that reduce hospitalizations and drug use.
  • Collaboration among clinical specialists, biomedical engineers, and patient advocacy groups is accelerating product development and facilitating broader patient access.
  • Emerging trends point to greater use of digital health tools, offering remote programming, patient engagement, and expanded outpatient applications.
  • Distinct segmentation by device type, control mechanism, user demographics, and therapeutic indications enables tailored go-to-market strategies for sustained growth.

Tariff Impact: Navigating New Regulatory and Supply Chain Pressures

The scheduled implementation of U.S. tariffs on core neuromodulation device components in 2025 introduces significant challenges in cost management and global supply chain strategies. Manufacturers are responding with supplier diversification, local manufacturing initiatives, and targeted component redesigns to maintain market competitiveness and supply continuity. Adherence to stringent quality standards remains paramount as supply ecosystems evolve.

Methodology & Data Sources

The report utilizes a blend of secondary research—drawing from peer-reviewed journals, clinical trial registries, patent databases, and regulatory filings—and primary research via in-depth interviews with clinical experts and industry stakeholders. Data triangulation and regular methodological audits ensure robust, validated insights for high-stakes decision-making.

Why This Report Matters

  • Enables C-suite executives and strategy leaders to identify highest-potential growth opportunities and anticipate market disruptions.
  • Provides clarity on emerging regulatory, reimbursement, and technological landscapes shaping neuromodulation adoption worldwide.
  • Equips teams with actionable intelligence on segment-specific trends for effective capital allocation and partnership planning.

Conclusion

As neuromodulation devices advance in precision and expand therapeutic impact, organizations positioned at the convergence of innovation, compliance, and clinical need will secure long-term market leadership. Strategic focus on collaboration and operational agility is essential for sustaining competitive advantage in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of closed-loop deep brain stimulation systems for personalized neurological therapies
5.2. Integration of noninvasive transcranial magnetic stimulation devices with wearable health monitors
5.3. Advancements in implantable vagus nerve stimulators for treatment-resistant epilepsy and depression
5.4. Emerging optogenetic neuromodulation approaches for precise wireless neural circuit control
5.5. Regulatory approval pathways streamlining novel neuromodulation device clinical trials globally
5.6. Adoption of AI algorithms to optimize stimulation parameters in real time for patient outcomes
5.7. Rising investment in miniaturized neuromodulation systems enabling at-home patient therapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuromodulation Devices Market, by Device Type
8.1. Introduction
8.2. Invasive Devices
8.2.1. Deep Brain Stimulators
8.2.2. Sacral Nerve Stimulators
8.2.3. Spinal Cord Stimulators
8.2.4. Vagus Nerve Stimulators
8.3. Noninvasive Devices
8.3.1. Transcranial Direct Current Stimulation
8.3.2. Transcranial Magnetic Stimulation
9. Neuromodulation Devices Market, by Control Mechanism
9.1. Introduction
9.2. Closed Loop
9.3. Open Loop
10. Neuromodulation Devices Market, by Technology
10.1. Introduction
10.2. Electrical Stimulation
10.3. Magnetic Stimulation
10.4. Optogenetic Stimulation
10.5. Ultrasonic Stimulation
11. Neuromodulation Devices Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Neuromodulation Devices Market, by Therapeutic Area
12.1. Introduction
12.2. Gastrointestinal & Urological Disorders
12.3. Neurological Disorders
12.3.1. Dystonia
12.3.2. Epilepsy
12.3.3. Parkinson’s Disease
12.4. Pain Management
12.4.1. Chronic Pain
12.4.2. Neuropathic Pain
12.5. Psychiatric Disorders
12.5.1. Depression
12.5.2. Obsessive-Compulsive Disorder
13. Neuromodulation Devices Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Clinics
13.4. Hospitals
13.5. Research Institutes
14. Neuromodulation Devices Market, by Distribution Channel
14.1. Introduction
14.2. Offline
14.3. Online
15. Americas Neuromodulation Devices Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Neuromodulation Devices Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Neuromodulation Devices Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Aleva Neurotherapeutics SA
18.3.3. Biotronik SE & Co. KG
18.3.4. Boston Scientific Corporation
18.3.5. BrainsWay Ltd.
18.3.6. ElectroCore, Inc.
18.3.7. Integer Holdings Corporation
18.3.8. Laborie
18.3.9. Life Science Outsourcing, Inc.
18.3.10. LivaNova PLC
18.3.11. Medtronic plc
18.3.12. Neuromod Devices Limited
18.3.13. Neuronetics, Inc.
18.3.14. Neuropace Inc.
18.3.15. NeuroSigma, Inc.
18.3.16. Nexstim Oyj
18.3.17. Saluda Medical Pty Ltd
18.3.18. Soterix Medical Inc.
18.3.19. Synapse Biomedical Inc.
18.3.20. Synergia Medical SA
18.3.21. tVNS Technologies GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. NEUROMODULATION DEVICES MARKET: RESEARCHAI
FIGURE 30. NEUROMODULATION DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 31. NEUROMODULATION DEVICES MARKET: RESEARCHCONTACTS
FIGURE 32. NEUROMODULATION DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MAGNETIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MAGNETIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPTOGENETIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPTOGENETIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ULTRASONIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ULTRASONIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GASTROINTESTINAL & UROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GASTROINTESTINAL & UROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DYSTONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 156. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 157. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 158. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 159. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 160. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 161. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 166. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 167. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 168. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 169. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 170. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 171. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 172. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 173. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 184. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 185. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 194. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 195. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 300. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 301. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2024 (USD MILLION)
TABLE 306. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025-2030 (USD MILLION)
TABLE 307. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 312. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 313. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neuromodulation Devices market report include:
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrainsWay Ltd.
  • ElectroCore, Inc.
  • Integer Holdings Corporation
  • Laborie
  • Life Science Outsourcing, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Neuromod Devices Limited
  • Neuronetics, Inc.
  • Neuropace Inc.
  • NeuroSigma, Inc.
  • Nexstim Oyj
  • Saluda Medical Pty Ltd
  • Soterix Medical Inc.
  • Synapse Biomedical Inc.
  • Synergia Medical SA
  • tVNS Technologies GmbH

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.8 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Neuromodulation Market by Product Type (Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Depression, Epilepsy), End User, Technology - Global Forecast 2025-2030 - Product Image

Neuromodulation Market by Product Type (Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Depression, Epilepsy), End User, Technology - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030 - Product Image

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Neuromodulation Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Neuromodulation Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Internal Neuromodulation Devices Market Report 2025 - Product Image

Internal Neuromodulation Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.